既存轻度认知障碍与痴呆对急性缺血性卒中治疗接受度的影响
基于脑卒中监测项目2008至2013年836例≥45岁急性缺血性卒中患者,比较既存痴呆、轻度认知障碍(MCI)与认知正常者的治疗接受情况。结果显示痴呆患者复合质量评分未显著降低,但MCI与静脉tPA、康复评估和超声心动图接受率降低独立相关,痴呆与第2天抗血栓治疗和超声心动图接受率降低独立相关。
要点
- 既存MCI与静脉tPA(acOR=0.36)、康复评估(acOR=0.28)和超声心动图(acOR=0.48)接受率降低独立相关。
- 既存痴呆与第2天抗血栓治疗(acOR=0.39)和超声心动图(acOR=0.42)接受率降低独立相关。
- 痴呆与复合质量评分的关联在调整患者因素后不再显著(acOR=0.79,P=0.19)。
核心结论
- 既存MCI和痴呆患者较认知正常者可能较少接受某些急性缺血性卒中治疗与操作,但复合质量评分未显示差异。
研究设计与样本
- 基于Corpus Christi脑卒中监测项目2008至2013年前瞻性数据的横断面分析,纳入836例≥45岁急性缺血性卒中成人。
- 采用 Informant Questionnaire on Cognitive Decline in the Elderly 评分分组:痴呆≥3.44,MCI 3.1–3.43,认知正常≤3。
主要发现
- 认知正常占42%(女性47%,中位年龄65[56–76]),MCI占32%(女性54%,中位年龄70[60–78]),痴呆占26%(女性56%,中位年龄78[64–85])。
- 接受无缺陷治疗者:既存痴呆44%,既存MCI或认知正常55%。
- 与认知正常者相比,MCI者复合质量评分的未调整累积比值比为0.99(P=0.92),痴呆者为0.64(P=0.005)。
- 调整性别、合并症和体重指数后,痴呆与复合质量评分的关联不再显著(acOR=0.79,P=0.19)。
关键数值与推荐
- MCI与静脉tPA接受率降低独立相关(acOR=0.36,P=0.04)。
- MCI与康复评估接受率降低独立相关(acOR=0.28,P=0.016)。
- MCI与超声心动图接受率降低独立相关(acOR=0.48,P<0.001)。
- 痴呆与第2天抗血栓治疗接受率降低独立相关(acOR=0.39,P=0.04)。
- 痴呆与超声心动图接受率降低独立相关(acOR=0.42,P<0.001)。
临床怎么用
- 对既存MCI或痴呆的急性缺血性卒中患者,应关注静脉tPA、康复评估、超声心动图和早期抗血栓等治疗是否被遗漏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Differences in acute ischemic stroke (AIS) treatment by cognitive status are unclear, but some studies have found patients with preexisting dementia get less treatment. We compared AIS care by preexisting cognitive status. METHODS: Cross-sectional analysis of prospectively obtained data on 836 adults ≥45 with AIS from the population-based Brain Attack Surveillance in Corpus Christi project from 2008 to 2013. We compared receipt of a composite quality measure representing the percentage of 7 treatments/procedures received (ordinal scale; values, <0.75, 0.75-0.99, and 1.0), a binary defect-free quality score, and individual treatments after AIS between patients with preexisting dementia (Informant Questionnaire on Cognitive Decline in the Elderly score ≥3.44), mild cognitive impairment (MCI, score 3.1-3.43), and normal cognition (score ≤3). RESULTS: Among patients with AIS, 42% had normal cognition (47% women; median age [interquartile range], 65 [56-76]), 32% had MCI (54% women; median age, 70 [60-78]), 26% had dementia (56% women; median age, 78 [64-85]). After AIS, 44% of patients with preexisting dementia and 55% of patients with preexisting MCI or normal cognition received defect-free care. Compared with cognitively normal patients, patients with preexisting MCI had similar cumulative odds (unadjusted cumulative odds ratio =0.99, P=0.92), and patients with preexisting dementia had 36% lower cumulative odds of receiving the composite quality measure (unadjusted cumulative odds ratio [OR]=0.64, P=0.005). However, the dementia-quality association became nonsignificant after adjusting for patient factors, namely sex, comorbidity, and body mass index (adjusted cumulative OR [acOR]=0.79, P=0.19). Independent of patient factors, preexisting MCI was negatively associated with receipt of IV tPA (intravenous tissue-type plasminogen activator; acOR=0.36, P=0.04), rehabilitation assessment (acOR=0.28, P=0.016), and echocardiogram (acOR=0.48, P<0.001). Preexisting dementia was negatively associated with receipt of antithrombotic by day 2 (acOR=0.39, P=0.04) and echocardiogram (acOR=0.42, P<0.001). CONCLUSIONS: Patients with preexisting MCI and dementia, compared with cognitively normal patients, may receive less frequently some treatments and procedures, but not the composite quality measure, after AIS.
引用
- Levine DA, Galecki AT, Morgenstern LB, et al. Preexisting Mild Cognitive Impairment, Dementia, and Receipt of Treatments for Acute Ischemic Stroke. Stroke. 2021. PMID: 33902296. doi:10.1161/STROKEAHA.120.032258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。